Happy News! GSK (GSK) Just Paid $367 Million, for Synvidia’s Pre-Clinical Trial Cancer Treatment.
One of the Fun Features of Biotech Investing, is Getting Paid on a Treatment That Hasn't Even Entered Clinical Trials.
A lot of investors...
Adding Oncolytics Biotech Inc. (ONCY) $1.02 to 2025 Watch List.
The Oncolytics Biotech Inc. (ONCY) idea is coming from one of our top 'tipsters' the Big Wig - whose two previous ideas, Allarity (ALLR)...
We’re Up 118% on Allarity (ALLR) Today.
Since adding Allarity (ALLR) to the Watch List at $0.70, we are up 194%, and that ain't bad - for exactly 4 months and...
GeoVax Report (GOVX) $0.69. From Crystal Research.
July 2025 Update on GeoVax Labs, Inc. (GOVX-NASDAQ)
Crystal Research Associates has issued a 16-page Company Update on clinical-stage biotechnology company, GeoVax Labs, Inc. (GOVX-NASDAQ).
Snapshot...
GeoVax (GOVX) Comments on HHS mRNA Vaccine Rollback: Urges Full Embrace of MVA-Based Multi-Antigen...
https://youtu.be/4LffUyg6yE8?si=G8_kZMce8yHGCxKp
GEO-CM04S1 Offers Solution to Overcome HHS-Cited mRNA Deficiencies - Potentially Offering Broader, More Durable Protection
ATLANTA, GA - August 7, 2025 (NEWMEDIAWIRE) - GeoVax Labs,...
Compass Pathways (CMPS) $4.44, Gains 85% Since Adding to Watch List.
Down from $56.95 - But Up from $2.36. Woo hoo!
Compass Pathways (CMPS) Gets a Beat Down. Adding to 2025 Watch List, $2.36
We are probably...
TWO DOUBLES, From the Same Stock! Bavarian Nordic (BVRNY) $12.25, gains 149% After Adding...
Been quite sometime since we had Watch List company taken out, at over $1 Billion but here we go again. With our 4th billion...
Vystar (VYST)$0.16. While Shares not yet Actively Trading, Gains 54% From Adding to Watch...
World's Best Air Purifier, FDA Cleared (Medical), Gets a Boost.
(Just to be clear, this is not your everyday $200 Walmart air cleaner, using HEPA...
GeoVax (GOVX) Accelerates Development of GEO-MVA Vaccine Amid Expanding Global Mpox Crisis and Reaffirmed...
EMA Scientific Guidance, Global Surge in Clade I Mpox, and Aid Shortfalls Drive Urgent Need for Scalable, Equitable Vaccine Solutions
LIVE QUOTE
ATLANTA, GA - July...
Cardiol Therapeutics (CRDL) May 2025 Presentation.
Click here to open.
RELATED: Cardiol’s (CRDL) Game-Changing Solution for Heart Inflammation? | David Elsley CEO – Video Interview
Latest article
Latest Research Report: $20 Price Target from Greenridge Global.
Here are four research reports below to peruse, all with price targets $20.00 or more...
While we don't issue price targets, it's comforting to see...
Three More Companies Suspended by SEC!
Millions of Investor's Dollars are Being Trapped.
These three companies had a combined market cap of $563 million at the time they were halted, whose...
AI Data Center Short – Jim Chanos
“If the economic life on these things is three years ... the whole economics of a lot of these deals kind of falls...
